Clinical data management

Clinical Data Strategy in Action for Complex Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, April 8, 2024
Machine learning, Collection, Data management, Artificial intelligence, Acquisition, Clinical data management, Drug development, Medical imaging

TORONTO, April 8, 2024 /PRNewswire-PRWeb/ -- The need for more efficient, patient-centric approaches in drug development is ushering in a new era of innovative clinical trials such as master protocols and adaptive designs that enhance flexibility and accelerate the identification of effective treatments. While these novel approaches are vital tools for improving patient outcomes, especially within oncology and rare diseases, they significantly increase the complexity of data handling, from collection to analysis. This complexity mirrors a wider shift in clinical research towards a more data-rich environment drawing on a wider variety of emerging data sources.

Key Points: 
  • The featured speakers will discuss how real-time access to data enhances operational efficiency and supports more informed strategic decision-making within complex trial designs.
  • Close alignment across clinical data functions provides a robust foundation that enhances adaptive capabilities, reduces data bottlenecks and inefficiencies and supports more informed, timely decision-making.
  • This webinar brings together clinical data experts from clinical data acquisition, data management and statistical analysis disciplines for an interactive conversation exploring the vital roles of technology, collaboration, and flexibility in navigating the complexities of today'sclinical trials.
  • Register for this webinar today to learn how a unified clinical data strategy, advanced clinical data technologies and real-time data access can streamline complex clinical trials.

Lindus Health Unveils Versatile "All-in-One Respiratory CRO" Offering Tailored to Respiratory Clinical Trials

Retrieved on: 
Tuesday, April 2, 2024
Sleep apnea, Pneumonia, MIT, Electronic data capture, Patient, Chronic obstructive pulmonary disease, Research, Pi, Health information management, EDC, Electronic health record, MD, Respiratory disease, Asthma, CTMS, Housing, Clinical trial management system, COPD, Data management, AptarGroup, Clinical data management, Fine chemical

Lindus Health has enrolled over 6,500 patients in respiratory clinical trials within the US, UK and Europe to date, showcasing their extensive resume of experience within this therapeutic area.

Key Points: 
  • Lindus Health has enrolled over 6,500 patients in respiratory clinical trials within the US, UK and Europe to date, showcasing their extensive resume of experience within this therapeutic area.
  • "We're thrilled to be launching a bespoke CRO offering to respiratory disease sponsors to mitigate the challenges faced in bringing essential respiratory therapies to market."
  • Deep regulatory and therapeutic area-specific expertise: Bringing together various research backgrounds, the Lindus Health team resumes exceptional expertise within respiratory clinical trials and the ever-changing regulatory landscapes of the US, UK, and EU.
  • Lindus Health is committed to leading successful respiratory research, providing a robust and efficient framework for clinical trials from inception to completion, and enhancing the experience for both sponsors and participants.

Vita Global Sciences Announces Strategic Partnership with Anju Software

Retrieved on: 
Tuesday, March 26, 2024
Clinical data management, Partnership, SVP, EDC, VITA, CTMS, Data collection, Clinical trial, Ecosystem, Health, Nursing

FORT LAUDERDALE, Fla., March 26, 2024 /PRNewswire/ -- Vita Global Sciences , provider of professional services for the life sciences industry, is thrilled to announce its strategic partnership with Anju Software, a global provider of life science technologies.

Key Points: 
  • FORT LAUDERDALE, Fla., March 26, 2024 /PRNewswire/ -- Vita Global Sciences , provider of professional services for the life sciences industry, is thrilled to announce its strategic partnership with Anju Software, a global provider of life science technologies.
  • VITA and Anju have joined forces to integrate Anju's cutting-edge eClinical solutions into VITA's comprehensive ecosystem.
  • "We are thrilled to partner with Anju, allowing us to offer their industry-leading solutions to our customers," stated Kelly Forester, Director of Clinical Data Management at Vita Global Sciences.
  • Anju brings decades of experience and expertise in developing comprehensive software solutions tailored to the evolving needs of the clinical research community.

Premier Pediatric Research Center Adopts Complion's eISF Platform to Strengthen Pediatric Research Excellence

Retrieved on: 
Tuesday, March 26, 2024
AUC, ChromeOS, SAN, Factorization of polynomials, Data management, Research, Clinical trial, Clinical data management, Nursing

This collaboration marks a significant milestone, as another of the nation's top 10 pediatric research institutions has chosen Complion's sophisticated eISF system to improve compliance and data management processes across its research endeavors.

Key Points: 
  • This collaboration marks a significant milestone, as another of the nation's top 10 pediatric research institutions has chosen Complion's sophisticated eISF system to improve compliance and data management processes across its research endeavors.
  • As a leading pediatric medical center overseeing almost 150 ongoing studies across its research portfolios, this world-class institution sought an exceptional eClinical solution to meet the demands of its complex pediatric clinical research.
  • Complion was chosen because of its ability to simplify research workflows by converting manual, time-consuming tasks into automated, efficient operations.
  • Complion's eISF system is distinguished by its targeted design, developed to meet the unique requirements of complex pediatric clinical research.

Clinical Trial Supply & Logistics Market Projected to Reach $41.04 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Monday, March 25, 2024
Catalent, Medical device, Temperature, Growth, Prevalence, Face, Molecule, Thermo Fisher Scientific, Medication, CTSL, Pharmacy, Partnership, Intelligence, Imp, Conditional sentence, ICON, Global health, Research, Good manufacturing practice, IMP, Transport, ICON PLC, Placebo, Infosys, GMP, Excipient, Investment, Clinical trial, GDP, Drug development, API, Clinical data management, Table, Ageing, Parexel

"Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"

Key Points: 
  • "Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"
    Clinical trial supply and logistics (CTSL) is a critical backbone for conducting clinical studies worldwide, providing essential services, including planning, storing, managing, and distributing clinical trial materials (CTMs).
  • South America also sees increased adoption of clinical trial supply and logistics, fueled by its developing healthcare infrastructure.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trial Supply & Logistics Market.
  • "Dive into the Clinical Trial Supply & Logistics Market Landscape: Explore 187 Pages of Insights, 582 Tables, and 26 Figures"

Clinical Trial Supply & Logistics Market Projected to Reach $41.04 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Monday, March 25, 2024
Catalent, Medical device, Temperature, Growth, Prevalence, Face, Molecule, Thermo Fisher Scientific, Medication, CTSL, Pharmacy, Partnership, Intelligence, Imp, Conditional sentence, ICON, Global health, Research, Good manufacturing practice, IMP, Transport, ICON PLC, Placebo, Infosys, GMP, Excipient, Investment, Clinical trial, GDP, Drug development, API, Clinical data management, Table, Ageing, Parexel

"Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"

Key Points: 
  • "Global Growth Trends in Clinical Trial Supply & Logistics: Navigating Challenges, Driving Innovation"
    Clinical trial supply and logistics (CTSL) is a critical backbone for conducting clinical studies worldwide, providing essential services, including planning, storing, managing, and distributing clinical trial materials (CTMs).
  • South America also sees increased adoption of clinical trial supply and logistics, fueled by its developing healthcare infrastructure.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trial Supply & Logistics Market.
  • "Dive into the Clinical Trial Supply & Logistics Market Landscape: Explore 187 Pages of Insights, 582 Tables, and 26 Figures"

Lindus Health Introduces Comprehensive "All-In-One CRO" Package for CNS, Neurology, and Psychiatric Clinical Trials

Retrieved on: 
Tuesday, March 19, 2024
Principal, Neurology, Database, Psychiatry, MIT, Electronic data capture, Patient, CNS, Research, Health information management, EDC, Neuro, CTMS, Clinical trial management system, CMO, Data management, Clinical data management, Pharmaceutical industry

NEW YORK, March 19, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched an all-in-one package of contract research organization (CRO) services tailored for CNS, neurology, and psychiatric clinical trials.

Key Points: 
  • NEW YORK, March 19, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched an all-in-one package of contract research organization (CRO) services tailored for CNS, neurology, and psychiatric clinical trials.
  • The "All-In-One CNS, Neurology and Psychiatry CRO" empowers sponsors within these therapeutic areas to execute more nimble and successful clinical trials.
  • Advanced patient recruitment strategies: Lindus Health supports neurology study sponsors in meeting their enrollment objectives efficiently through diverse recruitment tactics.
  • Lindus Health is dedicated to advancing CNS research, offering a robust solution for faster and more effective clinical trials while delivering exceptional clinical trial experiences for both sponsors and patients.

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Retrieved on: 
Monday, March 11, 2024
Sidley Austin, Clinical data management, Growth, Digital, HUB, Patient, LLP, Barclays

DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has signed a definitive agreement to divest assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare companies.

Key Points: 
  • “After undertaking a strategic review of our business, divesting Endpoint and Fortrea Patient Access aligns with the interests of our customers.
  • “These businesses will be distinctively positioned to effectively manage the patient journey across clinical trials and into commercialization by driving patient access and adherence for approved therapies.
  • Dimitris Agrafiotis, Ph.D., Director of Digital, Analytics & AI at Arsenal said, “Endpoint and Fortrea Patient Access provide essential solutions that enable patients’ participation in clinical trials and access to therapies.
  • Fortrea Patient Access is a scaled leader in the HUB services and patient access market, serving the biopharmaceutical industry with comprehensive patient support, product access, affordability and adherence solutions for more than 30 years.

EClinical Solutions Market size to grow by USD 9.7 billion from 2022 to 2027, North America to account for 41% of market growth, Technavio

Retrieved on: 
Wednesday, March 6, 2024
Research, Biotechnology, USD, Artificial intelligence, Clinical data management, Investment, CTMS, Data management, Growth, Drug development, Geography, World Games, ChromeOS, Data analysis, Clinical trial, Cloud computing, Machine learning, Workforce, ROW, Pharmaceutical industry

NEW YORK, March 6, 2024 /PRNewswire/ -- The eclinical solutions market is expected to grow by USD 9.7 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, March 6, 2024 /PRNewswire/ -- The eclinical solutions market is expected to grow by USD 9.7 billion from 2022 to 2027.
  • In addition, the momentum of the market will progress at a CAGR of  13.47% during the forecast period, according to Technavio Research.
  • This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment.
  • The global rehabilitation equipment market size is estimated to grow by USD 3.67 billion at a CAGR of 4.44% between 2023 and 2028.

eClinical Solutions Highlights Notable Year of Growth Supporting Biopharma's Complex Data Demands

Retrieved on: 
Thursday, February 15, 2024
Health, Technology, Health Technology, Software, Clinical Trials, Pharmaceutical, Biotechnology, ISO, Innovation, Information, Compensation and benefits, Clinical data management, AI, Compensation, Drug development, ISMS, Gartner, PIMS, FSP, International Organization for Standardization, SCE, ChromeOS, Certification, Automation, Statistics, Snowflake, AWS

eClinical Solutions was recognized as a leader in the inaugural Life Sciences Clinical Data and Analytics Platforms PEAK Matrix® Assessment 2023 , ranking highest among all 14 listed platform providers in vision & capability, which measures ability to deliver product successfully.

Key Points: 
  • eClinical Solutions was recognized as a leader in the inaugural Life Sciences Clinical Data and Analytics Platforms PEAK Matrix® Assessment 2023 , ranking highest among all 14 listed platform providers in vision & capability, which measures ability to deliver product successfully.
  • The honor underscores eClinical’s achievement in creating and leading the data infrastructure and analytics industry category.
  • “The past year affirmed our commitment to client excellence, innovation, and cycle time efficiency through AI-powered data products and biometrics services.
  • “Our growth is not only about extending our reach, but also deepening the impact, value and ROI we deliver.